Month: July 2023

Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease at the Alzheimer’s Association International Conference (AAIC) 2023

Staff July 16, 2023

Figure 1 Acumen Pharmaceuticals, Inc. Figure 2 Acumen Pharmaceuticals, Inc.Topline results from INTERCEPT-AD trial met primary and secondary objectives, demonstrating...

Algernon Pharmaceuticals Announces Private Placement and Issuance of Shares in Connection with Financial Advisory Agreement

Staff July 15, 2023

VANCOUVER, British Columbia, July 14, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or...

Atlas Global Brands Announces Delay in Annual and Interim Filings Following Complex Reverse Takeover, Acquisitions and Corporate Restructuring

Staff July 15, 2023

CHATHAM, ONTARIO and TEL-AVIV, ISRAEL, July 14, 2023 (GLOBE NEWSWIRE) -- Atlas Global Brands Inc. (“Atlas Global” or the “Company”)...

Red White & Bloom and Aleafia Health Mutually Agree to Terminate Binding Letter Agreement

Staff July 15, 2023

TORONTO, July 14, 2023 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or...

BridgeBio to Host Investor Call to Share Topline 30-month Results from the Phase 3 ATTRibute-CM Study in Patients with Transthyretin Amyloid Cardiomyopathy on July 17, 2023

Staff July 15, 2023

PALO ALTO, Calif., July 14, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused...

Phreesia Acquires MediFind, Reinforcing its Commitment to Patient-Centered Care and Expanding its Offerings to Consumers

Staff July 14, 2023

WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, is pleased to announce it has acquired Comsort, Inc....

Intellipharmaceutics Announces Second Quarter 2023 Results

Staff July 14, 2023

TORONTO, ON / ACCESSWIRE / July 14, 2023 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a...

Neural Therapeutics Inc. Closes Rights Offering

Staff July 14, 2023

Toronto, Ontario--(Newsfile Corp. - July 14, 2023) - Neural Therapeutics Inc. (the "Company" or "Neural"), an ethnobotanical drug-discovery and development...

LevelJump Healthcare Corp. Announces Preferred Share Offering Increased to 12% Dividend, Reduced Conversion Price

Staff July 14, 2023

Toronto, Ontario--(Newsfile Corp. - July 14, 2023) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the...

POP Biotechnologies and EuBiologics’ EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial

Staff July 14, 2023

BUFFALO, NY / ACCESSWIRE / July 14, 2023 / POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical startup, announces top...

SupportDDS Welcomes Chief Growth Officer, RCM Solutions, Victoria Johnson

Staff July 14, 2023

ARGYLE, TX / ACCESSWIRE / July 14, 2023 / SupportDDS is pleased to announce the appointment of Victoria Johnson as...

Whittier Street Health Center’s 24th Annual Men’s Health Summit a Triumph

Staff July 14, 2023

BOSTON, MA / ACCESSWIRE / July 14, 2023 / Whittier Street Health Center, a community health center with a mission...

Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission

Staff July 14, 2023

Company targeting FDA submission in the first half of 2024AVERSA™ Fentanyl is the flagship product of the Company's AVERSA™ PlatformORLANDO,...

ReCor Responds to European Society of Hypertension’s (ESH) Updated Guidelines for Management of Arterial Hypertension

Staff July 14, 2023

Treating hypertension is complex, and European guidelines reinforce the safety and effectiveness of renal denervation as a treatment option to...

CurvaFix Closes $39 Million Series C Financing Round Led by MVM Partners and Announces CEO Transition

Staff July 14, 2023

BELLEVUE, Wash.--(BUSINESS WIRE)--#CurvaFix--CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the close of...

Curated Mental Health Emphasizes the Importance of Professional Support in Psychedelic Therapy for Optimal Mental Health Outcomes

Staff July 14, 2023

NEW YORK, NY / ACCESSWIRE / July 14, 2023 / Is ketamine a powerful tool for therapeutic purposes? Absolutely. But...

Month: July 2023

Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease at the Alzheimer’s Association International Conference (AAIC) 2023

Algernon Pharmaceuticals Announces Private Placement and Issuance of Shares in Connection with Financial Advisory Agreement

Atlas Global Brands Announces Delay in Annual and Interim Filings Following Complex Reverse Takeover, Acquisitions and Corporate Restructuring

Red White & Bloom and Aleafia Health Mutually Agree to Terminate Binding Letter Agreement

BridgeBio to Host Investor Call to Share Topline 30-month Results from the Phase 3 ATTRibute-CM Study in Patients with Transthyretin Amyloid Cardiomyopathy on July 17, 2023

Phreesia Acquires MediFind, Reinforcing its Commitment to Patient-Centered Care and Expanding its Offerings to Consumers

Intellipharmaceutics Announces Second Quarter 2023 Results

Neural Therapeutics Inc. Closes Rights Offering

LevelJump Healthcare Corp. Announces Preferred Share Offering Increased to 12% Dividend, Reduced Conversion Price

POP Biotechnologies and EuBiologics’ EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial

SupportDDS Welcomes Chief Growth Officer, RCM Solutions, Victoria Johnson

Whittier Street Health Center’s 24th Annual Men’s Health Summit a Triumph

Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission

ReCor Responds to European Society of Hypertension’s (ESH) Updated Guidelines for Management of Arterial Hypertension

CurvaFix Closes $39 Million Series C Financing Round Led by MVM Partners and Announces CEO Transition

Curated Mental Health Emphasizes the Importance of Professional Support in Psychedelic Therapy for Optimal Mental Health Outcomes

ApolloMD Announces Winner of 2023 Emergency Medicine Scholarship for Residents

Eastern Carolina Emergency Physicians Joins Emergency Care Partners

CureVac Announces Update to the Management Team

Improving Quality in Northwest Clinics Through Chronic Care Management

GenSci and RTW Investments Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and Thyroid Eye Disease, With Global Ex-China Development Being Led by Yarrow Bioscience

New National Alliance Launches to Address Health Workforce Shortages in Underserved Communities

Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million

TempraMed Strengthens Global Intellectual Property Position with Grant of South Korean Patent

Functional Brands Announces Third Quarter 2025 Financial Results

You may have missed